Spurr Cl

414 total citations
20 papers, 326 citations indexed

About

Spurr Cl is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, Spurr Cl has authored 20 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Hematology and 4 papers in Genetics. Recurrent topics in Spurr Cl's work include Acute Myeloid Leukemia Research (4 papers), Cancer Treatment and Pharmacology (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Spurr Cl is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Cancer Treatment and Pharmacology (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Spurr Cl collaborates with scholars based in United States. Spurr Cl's co-authors include Frederick Richards, Cooper Mr, Muss Hb, Matthew Poole, Capizzi Rl, Emmanuel Keku, F.M. Richards, Miller Ec, Zak K. Shihabi and Max Haid and has published in prestigious journals such as PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

In The Last Decade

Spurr Cl

18 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Spurr Cl United States 8 132 113 111 74 70 20 326
Morwenna Till United Kingdom 8 151 1.1× 57 0.5× 78 0.7× 56 0.8× 131 1.9× 9 369
M Till United Kingdom 9 88 0.7× 71 0.6× 134 1.2× 55 0.7× 89 1.3× 14 352
P R Taylor United Kingdom 11 323 2.4× 137 1.2× 177 1.6× 158 2.1× 81 1.2× 20 517
A Boilletot France 9 76 0.6× 75 0.7× 87 0.8× 77 1.0× 21 0.3× 26 297
RM Lowenthal Australia 9 254 1.9× 184 1.6× 91 0.8× 166 2.2× 56 0.8× 20 451
A.K. Burnett United Kingdom 11 327 2.5× 127 1.1× 101 0.9× 95 1.3× 48 0.7× 22 449
C. F. Lucas United Kingdom 5 178 1.3× 35 0.3× 68 0.6× 31 0.4× 50 0.7× 7 321
G. J. Dovey United Kingdom 8 127 1.0× 72 0.6× 149 1.3× 165 2.2× 41 0.6× 10 369
D Hollard France 13 432 3.3× 118 1.0× 117 1.1× 102 1.4× 185 2.6× 56 612
C Stainer United Kingdom 11 282 2.1× 122 1.1× 49 0.4× 46 0.6× 84 1.2× 12 384

Countries citing papers authored by Spurr Cl

Since Specialization
Citations

This map shows the geographic impact of Spurr Cl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spurr Cl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spurr Cl more than expected).

Fields of papers citing papers by Spurr Cl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Spurr Cl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spurr Cl. The network helps show where Spurr Cl may publish in the future.

Co-authorship network of co-authors of Spurr Cl

This figure shows the co-authorship network connecting the top 25 collaborators of Spurr Cl. A scholar is included among the top collaborators of Spurr Cl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Spurr Cl. Spurr Cl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mr, Cooper, et al.. (1995). Community Clinical Oncology Program as a recruitment vehicle for cancer control research. The Southeast Cancer Control Consortium experience.. PubMed. 56(6). 283–6. 3 indexed citations
2.
Richards, Frederick, et al.. (1989). Chemoinfusion of the hepatic artery for metastases to the liver.. PubMed. 168(4). 291–5. 3 indexed citations
3.
Cl, Spurr, et al.. (1984). Glutamic acid modification of vincristine toxicity.. PubMed. 7(3). 245–52. 18 indexed citations
4.
Shihabi, Zak K., et al.. (1984). Increase of serum iron concentrations in rhesus monkeys and humans on administration of vincristine, vinblastine, or vindesine.. PubMed. 68(6). 933–6. 8 indexed citations
5.
Rl, Capizzi, Matthew Poole, Cooper Mr, et al.. (1984). Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase.. PubMed. 63(3). 694–700. 159 indexed citations
6.
Cl, Spurr, et al.. (1982). Pharmacokinetics of vincristine infusion.. PubMed. 65(11-12). 1043–8. 34 indexed citations
7.
Dresch, C, et al.. (1981). Resistance to therapy of acute leukemia developing in the course of polycythemia vera.. PubMed. 23(4). 187–92. 3 indexed citations
8.
Keku, Emmanuel, et al.. (1979). Absence of neutral protease and alkaline phosphatase in neutrophils of a case of hairy cell leukemia.. PubMed. 95(1). 55–66. 3 indexed citations
9.
Mr, Cooper, et al.. (1979). Complications of cytotoxic antineoplastic chemotherapy.. PubMed. 40(2). 73–8. 1 indexed citations
10.
Keku, Emmanuel, et al.. (1979). Monocyte and granulocyte defect in chronic lymphocytic leukemia.. PubMed. 95(1). 43–54. 33 indexed citations
11.
Hb, Muss, et al.. (1978). Vinblastine and 6-thioguanine in the treatment of advanced breast cancer.. PubMed. 62(8). 1233–5. 2 indexed citations
12.
Richards, Frederick, et al.. (1978). Chemoimmunotherapy for disseminated malignant melanoma: a prospective randomized study.. PubMed. 62(7). 1085–7. 7 indexed citations
13.
Haid, Max, et al.. (1977). Adriamycin-methotrexate combination chemotherapy of advanced carcinoma of the cervix.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 50(1). 103–5. 7 indexed citations
14.
Hb, Muss, et al.. (1976). Adriamycin and CCNU in the treatment of advanced breast cancer.. PubMed. 60(11). 1687–9. 7 indexed citations
15.
Richards, Frederick, et al.. (1974). Study of methyl-CCNU(NSC-95441) in the treatment of lung cancer.. PubMed. 57(4). 419–22. 1 indexed citations
16.
Cl, Spurr, et al.. (1962). Correlative studies of the chemotherapy of mouse and human plasmacytomas.. PubMed. 24. 1–6. 2 indexed citations
17.
Cl, Spurr, et al.. (1961). Von Recklinghausen's disease with massive intra-abdominal tumor and spontaneous hypoglycemia: metabolic studies before and after perfusion of abdominal cavity with nitrogen mustard.. PubMed. 10. 183–99. 30 indexed citations
18.
Cl, Spurr, et al.. (1961). The effect of 1-aminocyclopentane carboxylic acid (NSC-1026) on mouse plasmacytoma.. PubMed. 14. 91–2. 1 indexed citations
19.
Cl, Spurr, et al.. (1957). Newer anti-inflammatory steroids; mechanisms of action and therapeutic applications.. PubMed. 15(5). 105–24. 3 indexed citations
20.
Cl, Spurr, et al.. (1954). The treatment of the ambulatory hypertensive patient with hexamethonium administered orally.. PubMed. 5(4). 251–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026